Global Ltd Gull Sells 45,216 Shares of USANA Health Sciences, Inc. (USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 45,216 shares of the company’s stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $66.44, for a total value of $3,004,151.04. Following the completion of the transaction, the insider now directly owns 11,694,053 shares of the company’s stock, valued at approximately $776,952,881.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Global Ltd Gull also recently made the following trade(s):

  • On Monday, November 20th, Global Ltd Gull sold 39,751 shares of USANA Health Sciences stock. The shares were sold at an average price of $66.11, for a total value of $2,627,938.61.
  • On Thursday, November 16th, Global Ltd Gull sold 101,929 shares of USANA Health Sciences stock. The stock was sold at an average price of $66.05, for a total value of $6,732,410.45.
  • On Monday, November 13th, Global Ltd Gull sold 7,289 shares of USANA Health Sciences stock. The stock was sold at an average price of $66.01, for a total value of $481,146.89.
  • On Thursday, November 2nd, Global Ltd Gull sold 43,292 shares of USANA Health Sciences stock. The stock was sold at an average price of $65.25, for a total value of $2,824,803.00.
  • On Thursday, October 26th, Global Ltd Gull sold 60,871 shares of USANA Health Sciences stock. The stock was sold at an average price of $67.39, for a total value of $4,102,096.69.
  • On Monday, October 30th, Global Ltd Gull sold 93,443 shares of USANA Health Sciences stock. The shares were sold at an average price of $67.08, for a total value of $6,268,156.44.
  • On Thursday, September 14th, Global Ltd Gull sold 79,294 shares of USANA Health Sciences stock. The stock was sold at an average price of $57.61, for a total value of $4,568,127.34.
  • On Tuesday, September 5th, Global Ltd Gull sold 40,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $58.41, for a total value of $2,336,400.00.

Shares of USANA Health Sciences, Inc. (NYSE USNA) opened at $70.90 on Friday. The company has a market capitalization of $1,697.47, a P/E ratio of 18.72 and a beta of 1.08. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $72.80.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.91 by $0.11. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The business had revenue of $261.77 million for the quarter, compared to analysts’ expectations of $259.52 million. During the same period in the previous year, the firm posted $2.40 EPS. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. analysts expect that USANA Health Sciences, Inc. will post 3.7 EPS for the current year.

A number of analysts have commented on USNA shares. BidaskClub raised USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Thursday, October 26th. Pivotal Research lifted their price objective on USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, October 25th.

A number of large investors have recently added to or reduced their stakes in USNA. Renaissance Technologies LLC lifted its stake in USANA Health Sciences by 10.6% during the second quarter. Renaissance Technologies LLC now owns 1,948,266 shares of the company’s stock worth $124,884,000 after purchasing an additional 186,600 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of USANA Health Sciences by 711.5% during the second quarter. Arrowstreet Capital Limited Partnership now owns 91,409 shares of the company’s stock worth $5,859,000 after acquiring an additional 80,145 shares during the period. FMR LLC increased its position in shares of USANA Health Sciences by 3.9% during the second quarter. FMR LLC now owns 1,598,143 shares of the company’s stock worth $102,441,000 after acquiring an additional 60,033 shares during the period. Old Mutual Global Investors UK Ltd. increased its position in shares of USANA Health Sciences by 29.7% during the second quarter. Old Mutual Global Investors UK Ltd. now owns 239,680 shares of the company’s stock worth $15,363,000 after acquiring an additional 54,831 shares during the period. Finally, Schroder Investment Management Group increased its position in shares of USANA Health Sciences by 9.0% during the second quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock worth $36,734,000 after acquiring an additional 47,448 shares during the period. Institutional investors own 43.82% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first reported by Week Herald and is the property of of Week Herald. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://weekherald.com/2017/12/09/usana-health-sciences-inc-usna-major-shareholder-sells-3004151-04-in-stock.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply